Reproductive Biology and Endocrinology (May 2022)

Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction

  • Kai-Lun Hu,
  • Zimiao Chen,
  • Xiaoxue Li,
  • Enci Cai,
  • Haiyan Yang,
  • Yi Chen,
  • Congying Wang,
  • Liping Ju,
  • Wenhai Deng,
  • Liangshan Mu

DOI
https://doi.org/10.1186/s12958-022-00953-y
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Background Kisspeptin is the leading upstream regulator of pulsatile and surge Gonadotrophin-Releasing Hormone secretion (GnRH) in the hypothalamus, which acts as the key governor of the hypothalamic-pituitary-ovary axis. Main text Exogenous kisspeptin or its receptor agonist can stimulate GnRH release and subsequent physiological gonadotropin secretion in humans. Based on the role of kisspeptin in the hypothalamus, a broad application of kisspeptin and its receptor agonist has been recently uncovered in humans, including central control of ovulation, oocyte maturation (particularly in women at a high risk of ovarian hyperstimulation syndrome), test for GnRH neuronal function, and gatekeepers of puberty onset. In addition, the kisspeptin analogs, such as TAK-448, showed promising agonistic activity in healthy women as well as in women with hypothalamic amenorrhoea or polycystic ovary syndrome. Conclusion More clinical trials should focus on the therapeutic effect of kisspeptin, its receptor agonist and antagonist in women with reproductive disorders, such as hypothalamic amenorrhoea, polycystic ovary syndrome, and endometriosis.

Keywords